Poster boards dimensions will be provided in email correspondence to the Submitting Authors. The organizers will provide poster numbers and pushpins. From the accepted posters, a small number of highly rated abstract authors will also be invited to deliver short oral proffered presentations of their ...
BA3361, a CAB-ADC targeting Nectin-4, showed good in vitro and in vivo efficacy data demonstrating cytotoxicity against human Nectin-4-expressing tumor cell lines and tumor regression in xenograft models using the vedotin linker (AACR 2020, Poster #4560). To eliminate vedotin linker-related off-...
Henlius’ phase 3 clinical study of its innovative anti-PD-1 monoclonal antibody(mAb) HANSIZHUANG (serplulimab) as first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) was published as poster presentation...
February 9, 2022:Late-Breaking and Clinical Trials Abstract Status Notifications Sent/最新数据与临床试验摘要状态通知发送 February 11, 2022:Abstract Submission Deadline: Undergraduate Student Caucus and Poster Competition February 11, 2022:Membership Application Deadline for Advance Registration February 18, ...
March 18, 2022:Registration Deadline: Undergraduate Student Caucus and Poster Competition APRIL 2022 April 1, 2022:Membership Application Deadline to Register for the AACR Annual Meeting at the Member Rate On-Site April 8, 2022: On-Site Registration Opens at New Orleans Ernest N. Morial Conventio...
◆ 下次会议:2023年第7届CRI-ENCI-AACR国际癌症免疫治疗大会(CICON2023) ◆ 会议简介: 2022年第6届CRI-ENCI-AACR国际癌症免疫治疗大会将于2022年9月28日至10月1日在美国纽约举行,会议议题涵盖癌症免疫学和免疫治疗的所有研究领域。该会议于2015年启动,由癌症研究所(CRI)、欧洲癌症免疫治疗网络(ENCI)和美国癌症研...
Lunit said it will present five poster presentations featuring its AI-biomarker platform, Lunit SCOPE IO, during the 2023 American Association for Cancer Research (AACR) annual meeting in Orlando, Florida, from April 14-19.One of the studies to be presen
Study: Extend Quality Assessment to Phase I Abstracts: Poster Study at EORTC-NCI-AACR Meeting Gives Suggested Guidelinesdoi:10.1097/01.COT.0000343990.74265.d4An abstract is unavailable.Lindsey, HeatherOncology Times